LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...

BioArctic AB's (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) for Leqembi Iqlik subcutaneous ...

A Bayesian network meta-analysis comparing four oral JAK inhibitors-upadacitinib, abrocitinib, baricitinib, and ivarmacitinib ...

BYD’s 2025 sales total of 26,122 units represents a staggering 446% increase over its 2024 performance and makes up 94.14% of ...

The world of football witnessed another curious episode last Thursday (22).Coach Lúcio Flávio, who had arrived at Goiatuba ...

Creatine is a popular supplement used to increase muscle size and strength. There are a few medications and supplements you ...

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease FDA acti ...

GABA is a neurotransmitter that reduces brain activity, but it's also a supplement that could help with sleep.

A strategic partnership between Canada and China will force U.S. automakers to rethink the product mix if they want to stay ...

PRESS RELEASEAB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL ...

The witness, a former bank official, said the funds were disbursed based on the instructions of Mr Emefiele through his aide, ...

Chai and green tea share the same origins but differ in their constituents, flavors, health benefits, and taste.